Periodontitis is one of the most common oral diseases in humans. This caused by infection by the oral bacterium Porphyromonas gingivalis. Our strategy to prevent this infection is to establish a passive immunization system in which endogenous antibodies can be applied directly to neutralize virulent factors associated with this bacterium. We focused our attention on the P. gingivalis 35 kDa surface protein, or HBP35, since this protein is involved not only in the coaggregation with oral miroflora but also in hemin binding. In addition, nucleotide sequencing of the gene, hbp35, coding for this protein revealed the presence of a catalytic center for thioredoxin, and we further attempted to characterized the protein by amino acid substitution. A total of four Cys residues were substituted for Ser residues by combining the simple method for site-directed mutagenesis and the heterodimer system, an approach designed to construct chimeric plasmids readily. Native and mutagenized hbp35 were introduced into the Eschericha coli dsbA mutant strain, JCB 572, defective in both alkaline phosphatase and motile activities due to inefficient disulfide bond formation. Transformant harboring the native hbp35 could complement the dsbA mutation, suggesting a role of disulfide bond formation of this protein in P. gingivalis cells. Possible roles of the Cys residues in complementation are discussed.
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Periodontitis is one of the most common oral diseases in human which is brought by the infection of an anaerobic Gram-negative bacterium, Porphyromonas gingivalis. Possible invasive routes into host tissues incluede the following: coaggregation with oral microflora, such as Streptococcus gordonii; hemagglutination with erythrocytes followed by uptake of iron atoms; and attachment to host epithelial cells. Hence the proteins involved in each step are recognized to be virulent factors originating from this bacterium. Our approach to prevent this incidence is to establish a passive immunization system where endogenous antibody molecules could directly be applied. 1) Toward this goal, several virulent factors mentioned above have been examined. 2, 3) Among these, we focused our attention on the 35 kDa surface protein designated hemin binding protein 35, or HBP35, since it has been found that this protein is involved not only in the coaggregation toward S. gordonii but also in hemin binding. 4) The 2 kb EcoRI fragment from P. gingivalis chromosome containing the gene coding for the HBP35 was cloned and sequencing experiments revealed that the hbp35 consisted of several functional domains of which the most prominent one was the consensus sequence of the catalytic center for thioredoxin, EVFTAEWCGYCPGGK. The amino acid stretch Cys-x-x-Cys is essential to the enzyme protein possessing the thioredoxin activity, [5] [6] [7] since disulfide bond formation by non-enzymatic air oxidation is relatively inefficient and organisms ranging from bacteria to human are equipped with enzyme systems to catalyze this process. The reversible redox reaction occurring at the Cys residues provides the chemical potential for a number of biological reactions. In Escherichia coli, for example, dithiol oxidation takes place in the periplasm through the action of the Dsb family of proteins. Orthologs of DsbA are encoded in many Gram-negative bacteria, and have been found to play essential roles in the biogenesis of virulence factors and toxins in pathogenic organisms. [8] [9] [10] [11] However, no Dsb family homologs have been found in P. gingivalis W83, whose genes were listed in the TIGR data base. 12) To identify further the potential virulent factors associated with the HBP35, we performed functional analysis of this protein by amino acid substitution. To introduce site-directed mutagenesis, we exploited a simple, rapid, and inexpensive approach based on the utilization of only the T4 DNA polymerase, and all four codons coding for Cys residues present in the hbp35 were successfully altered to ones coding for Ser residues. In addition, the mutation points created were combined by a novel technique, designated the heterodimer system, 13) and plasmids with double and multiple mutations were also constructed.
The present communication describes these two techniques in detail. To evaluate the function of the HBP35, the mutagenized plasmids constructed were transformed into the E. coli disulfide bond formationdeficient strain, JCB 572, which is defective in alkaline phosphatase activity and shows poor motility on soft agar plate as well, due to inefficient S-S bond formation. The transformant harboring the plasmid with native hbp35 complemented the dsbA mutation, clearly indicating that the HBP35 might be involved in disulfide bond formation in P. gingivalis. The possible roles of the four Cys residues present in the HBP35 are discussed.
Experimental
Bacterial strains and plasmids. E. coli recombination-deficient strain JM109 was used. To evaluate the function of the HBP35, E. coli dsbA mutant strain, JCB 572, 14) defective in disulfide bond formation, was used as the host cells. This particular mutant exhibited only limited alkaline phosphatase activity, and poor motility on soft agar plate as well, due to inefficient S-S bond formation. 15 0 -moieties were annealed (E), filled-in, and ligated (F) in vivo. By screening the plasmids with mutagenic primer-specific restriction enzyme, the mutagenized plasmid was obtained with acceptable efficiency (G).
cloning plasmids, pResKmEco and pResAmpEco, respectively, and the 2 kb EcoRI fragment from the P. gingivalis chromosome containing the hbp35 gene (Genbank accession no. AB059658; gene ID, PG0554). The former two plasmids were derivatives of the progenitor plasmids, 16) composed of origin of replication from pACYC177 (p15A ori) and the drug-resistance gene, and contained only a single EcoRI site for cloning.
Site-directed mutagenesis. The HBP35 contains a total of four Cys residues at amino acid positions 48, 51, 113, and 161, and we attempted to substitute these residues for Ser residues (C48S, C51S, C113S, and C161S; hereafter abbreviated 1-Ser, 2-Ser, 3-Ser, and 4-Ser, respectively). In addition, 51Cys was also replaced with Ala (C51A, or 2-Ala).
To obtain two overlapping DNA fragments containing the mutation point, PCR experiments were carried out utilizing the primers shown in Fig. 2 . A typical PCR experiment proceeded as follows: plasmid pResKmEcoHBP35 was used as a template and PCR was carried out with a GeneAmp PCR system 9600 (Perkin-Elmer Corp., Norwalk, CT, USA). The target region was amplified using a TaKaRa Z-TaqÔ (Takara Shuzo Co., Ltd., Kyoto, Japan) under the following 30-cycles amplification: denaturation at 98 C for 5 s, primer annealing at 55 C for 10 s, and extension at 72 C for 20 s. To construct the plasmid with the double mutation, 1, 2-Ser, where the first two Cys residues were replaced, the plasmid, Km 1-Ser, was used as the template, instead of pResKmEcoHBP35. All PCR products were purified by ethanol precipitation and used in subsequent experiments. To minimize the appearance of background plasmids without mutations originating from the template plasmid, this PCR process was repeated under the exactly the same conditions, except that the template plasmid was replaced with purified primary PCR products at appropriate dilutions, and secondary PCR products were subjected to the next step.
Approximately 10 mg of each ethanol-precipitated secondary PCR product was combined and allowed to react with 20 units of restriction enzyme DpnI (New England BioLabs, Beverly, MA), at 37 C or 1 h, in a final volume of 50 ml, to selectively digest E. coli-borne A, The nucleotide and deduced amino acid sequences around the four Cys residues and the strategy for mutagenic PCR primer design. The target codons for Cys to Ser substitution are shadowed. To readily screen for the proper constructs, additional conservative mismatches were introduced to create new restriction sites. For example, BstEI and the SmaI site were embedded in mutagenic primers for the mutations of C48S and C51S, respectively. In addition, the BstUI-recognition sequence was embedded for the mutation C51A. B and C, Oligonucleotide sequences of the mutagenic forward and reverse primers for the single and double mutations, as well as C51A mutation, and the p15A forward and reverse primers are shown. The nucleotide coordinates for p15A ori were from pACYC177 (X06402). template plasmid. To this digest was added 6 units of T4 DNA polymerase (New England BioLabs) and incubated for 10 min at room temperature. This reaction mixture was heat-inactivated, ethanol-precipitated, and transformed into E. coli JM109 by electroporation. Mutagenized plasmids were screened by digesting them, with a mutagenic primer-specific restriction enzyme, and all mutation points were confirmed by nucleotide sequencing.
Mass spectroscopic analysis of the trypsinized peptide fragments. Recombinant HBP35 (rHBP35) and its variant proteins were purified to near homogeneity from sonicates of E. coli transformants harboring the respective plasmids, as reported previously. 17) These proteins were semi-automatically excised, and were treated with trypsin using Xcise, a high-throughput gel-excise processor (Shimadzu Biotech, Kyoto, Japan).
18) Concentration and desalination of the peptides after digestion were carried out successively using ZipTip -C18 (Millipore Corporation, Bedford, MA), after which the peptides were eluted directly onto a MALDI target with 1 ml of a saturated solution. -cyano-1-hydroxycinamic acid solution in 70% acetonitrile and 0.1% v/v trichloroacetic acid. Peptide mass analysis was carried out using an AXIMA CFR MALDI-TOF mass spectrometer (Shimadzu Biotech, Kyoto, Japan) in positive reflectron mode at an accelerating voltage of 20 kV. Proteins were identified from peptide mass data using the database search engine MASCOT (Matrix Science, Boston, MA), with a database for HBP35 that included mutagenic protein sequences. The following search parameters were used: trypsin was used as the enzyme, one missed cleavage was allowed, and carbamidomethyl and oxidized methionine were set as fixed and variable modifications, respectively.
Complementation of the E. coli dsbA mutation by the native and mutagenized hbp35. To determine whether the HBP35 could complement the dsbA mutation, E. coli strain JCB 572 was transformed with plasmids possessing native or mutagenized hbp35. Since this mutant possesses the kanamycin-resistant (Km r ) trait, all mutation points created were transported to ampicillinresistant (Ap r ) plasmids. No prominent growth difference was observed in any of these Ap r -transformants (data not shown).
To 2 ml of overnight culture of E. coli JCB572 harboring the respective Ap r plasmids was added 100 ml of toluene, and this was incubated for 30 min at room temperature, with occasional gentle shaking, to allow small molecules to penetrate inside the cells. After centrifugation, the recovered cells were re-suspended with 200 ml of TE. This toluenized cell suspension (20 ml) was incubated with 1 mM p-nitrophenylphosphate in 10 mM phosphate buffer, pH 9.0, at a final volume of 200 ml, at 37 C. After 1 h of incubation, the reaction was stopped by adding 10 ml of 1N NaOH, the cells were removed by centrifugation, and the absorbance (450 nm) of the supernatant (150 ml) was measured. One unit of compensatory activity was defined as the alkaline phosphatase activity that catalyzes the hydrolysis of the 1 mmole of substrate/min originating from the toluenized cells, corresponding to 200 ml of E. coli overnight culture.
Complementation of the motility on soft agar was evaluated as follows: an overnight culture (1 ml) of E. coli JCB572 harboring the respective Ap r plasmids was transferred into 1 ml of LB. This three orders of magnitude-diluted cell suspension (1 ml) was placed at the centers of L plates (35 mm in diameter) containing 0.1% agar and 10 mg/ml Ap, and incubated overnight at room temperature, and motility of each transformant on the surface of soft agar was photographed.
Result
Rapid introduction of site-directed mutagenesis by exonuclease-mediated zipper formation
Initially we attempted to construct the plasmid with a single mutation, utilizing pResKmHBP35 as a template, as outlined in Fig. 1 . To readily screen for the proper constructs, mutagenic primers were embedded in the specific restriction enzyme recognition sites around the mutation points, as shown in Fig. 2 . A total of four sets of overlapping secondary PCR products were prepared, and they were incubated with DpnI to digest dammethylated template plasmid, and simultaneously allowed to react with T4 DNA polymerase to produce a 3 0 -recessive structure. The reaction mixtures were heatinactivated, ethanol precipitated, and transformed directly into E. coli JM109. Since portions of the partially single-stranded 5 0 -moieties were complementary to each other, these regions were annealed (Fig. 1E) , filled in, and ligated (F) in vivo. Plasmids were extracted from the transformants and screened by digestion with mutagenic primer-specific restriction enzyme. Four mutagenized plasmids, Km 1-Ser, Km 2-Ser, Km 3-Ser, and Km 4-Ser, were successfully obtained with acceptable efficiency.
To construct the plasmid with a double mutation, Km 1, 2-Ser, the template plasmid, Km 1-Ser, instead of pResKmHBP35, was used. It was processed in the same way. In addition, the C51A mutation was also attempted, and Km 2-Ala was obtained.
Preparation of plasmids with multiple mutations with a heterodimer system
To prepare plasmids with multiple mutations, we employed a novel strategy, designated the heterodimer system. This approach allowed us to exchange certain fragments, flanked by unique restriction sites, from one plasmid to another, 13) as shown in Fig. 3 . pResAmpEcoHBP35 (A) is an additional parental plasmid whose structure is almost the same as that of pResKmEcoHBP35 (see Fig. 1B ), except that the drug-resistance gene is replaced with the Ap r gene. Km 3-Ser (B) is the Km r hbp35 plasmid with the C113S mutation. These two plasmids were mixed in a small tube, digested with PstI, and ligated. At this ligation, most of molecules were simply re-circularized to give the original plasmids, Ap HBP35 and Km 3-Ser. However, only small amounts of the two molecules were ligated to give a large hybrid plasmid, Ap r -Km r HD (C). When this ligation mixture was transformed into the E. coli recombination-deficient strain JM109, and selected the transformants on agar plates containing both Ap and Km, only hybrid plasmid could be recovered, because, due to plasmid compatibility, two different plasmids cannot co-exist in a single E. coli cell. Since this plasmid possesses the two p15A ori regions, it is a dimer, however, the drug-resistance genes are different. Therefore, this plasmid was referred to as a heterodimer plasmid.
13) The hybrid plasmid was digested with restriction enzyme MfeI, ligated, and transformed into E. coli JM109. By selecting the transformants on agar plates containing Ap, an E. coli strain harboring plasmid Ap 3-Ser (D) was obtained. Utilizing the heterodimer system, the mutation point was readily transported from the Km r plasmid (B) to the Ap r plasmid (D). Next, to construct the plasmid with the double mutation, Km 3, 4-Ser (F), Ap 3-Ser (D) and Km 4-Ser (E) were mixed in a single tube, and digested with restriction enzyme PstI, and the heterodimer plasmid was obtained (data not shown). Following the digestion of this heterodimer plasmid with restriction enzyme MfeI, ligation, transformation, and selection on Ap plates, E. coli transformant harboring the plasmid with the double mutation, Km 3, 4-Ser (F) was obtained (data not shown). To obtain the plasmid with multiple mutations, two mutation points present in Km 3, 4-Ser (F) were temporarily transported via heterodimer system to give Ap 3, 4-Ser (G). This plasmid was combined with another double mutant, Km 1, 2-Ser (H), and the plasmid with multiple mutation, Km 1, 2, 3, 4-Ser, (I) was obtained the heterodimer system (data not shown).
Western blot analysis of the crude lysate of E. coli transformants harboring the respective plasmids indicated the presence of immuno-positive proteins with the same molecular weights as that of authentic HBP35, suggesting that the variant protein can be produced in each transformant (Fig. 4) . However, this observation does not rule out unexpected amino acid substitutions, which give almost the same molecular weights, as that of native HBP35 on immunoblot analysis. To examine this possibility, all variant rHBP35 proteins were purified and subjected to mass spectroscopic analysis following trypsinization. As shown in Table 1 , the molecular weights of most of the tripsinized peptide fragments coincided with the calculated m=z ¼ Mw þ H or Mw. Although unexpected substitutions, such as Leu from/into Ile, could not be detected in this analysis, this observation strongly supports the idea that a high fidelity filling-in reaction can occur in vivo. Detection of the m=z values corresponding to fragments containing the Cys residue was impossible suggesting that a suitable reaction leading to S-methylation is necessary. In contrast, characteristic m=z values were observed in variant samples C113S and C161S (see Table 1 , shadowed values), each of which was exactly 16 massunits low as compared to those corresponding to Cyscontaining fragments. Since this difference was observed only when the sulfur atom was substituted for the oxygen atom, i.e., a Cys to Ser replacement, it is clear that the introduced substitution was confirmed not only at the nucleic acid but also at the protein level.
Complementation of the E. coli dsbA mutation by native and mutagenized hbp35 E. coli strain JCB 572 is defective in disulfide bond formation due to a mutation in the responsible gene, dsbA. As a consequence, this strain exhibited only limited alkaline phosphatase activity and poor motility on a soft agar plate. To evaluate the function of the 1 2 3 4 5 6 7 8 9 10 12 To rule out the possibility of unexpected mutation due to miss-incorporation during the filling-in reaction in vivo, native and variant rHBPs were purified and trypsized, after which peptide fragments were subjected to mass spectroscopic analysis. The boxed C indicates the calbamidomethylated for TOF-MS analysis.
HBP35, plasmids encoding native and valiant HBP35 were transformed, and both alkaline phosphatase activity and motility on soft agar plates were examined. As shown in Fig. 5 , transformation of native hbp35 restored alkaline phsphatase activity, clearly indicating that this gene complements the dsbA mutation. This complementation was diminished in those containing C48S and/or C51S. Mutations at C113S and/or C161S appeared to have no effect on the restoration of alkaline phosphatase activity. Finally, we examined the effect of HBP35 on motile activity. As shown in Fig. 6 , native hbp35 partly complemented this activity, while residual motile activity was completely abolished when the C48S mutation was introduced. Interestingly, single C51S mutation greatly enhanced motility, and this enhancement disappeared when this mutation was altered to C51A. On the other hand, mutations at C113S and/or C161S weakly affected the activity.
Discussion
Site-directed mutagenesis is one of the most powerful tools to evaluate protein function. Several PCR-based strategies have been published, and some of them are now commercially available. However, most of the commercially available kits appear to employ rather complex combinations of nucleases, each of which possesses unique substrate specificity, and hence utilization of these kits is expensive. This prompted us to develop a simple, rapid, and inexpensive approach to introduce mutagenesis. One technique we have referred to is the ligation-independent cloning of PCR products (LIC), reported by Charalampos Aslanidis and Pieter J. de Jong. 19) This approach relies on the fact that in the absence of dNTPs, T4 DNA polymerase exhibits ''processive'' -3 0 to -5 0 exonuclease activity, while an excess amount of nucleotide triphosphate derivative exists, which has the same base as that of the liberated nucleotide monophosphate by exonuclease activity, this enzyme repeats ''non-processive'' digestion and fillingin reactions, resulting in the apparent equilibration of nuclease and polymerase activities. Therefore, it is possible to obtain a DNA fragment with a defined 10 nucleotide-long 5 0 -extension structure by utilization of the PCR primers of which 5 0 -first 10 nucleotides lack one of the four bases, and incubation of the PCR product with a T4 DNA polymerase, in the presence of excess amounts of nucleotide triphosphate consisting of three out of four bases complementary to the first 10 nucleotides in the PCR primers. By processing the vector DNA whose terminal structures are complementary to the PCR primers in the same way, PCR products can be cloned with the aid of hydrogen bond formation in vivo.
We applied this approach to introduce site-directed mutagenesis, however, there existed a strict restriction on the choice of bases in designing mutagenic PCR primers, as compared to the LIC mentioned above. Overnight culture (1 ml) of E. coli JCB572 harboring the respective Ap r plasmid was transferred into 1 ml of LB. This three orders of magnitude-diluted cell suspension (1 ml) was placed at the centers of L plates (35 mm in diameter) containing 0.1% agar and 10 mg/ml Ap, and incubated overnight at room temperature, and motility of each transformant on soft agar surface was photographed.
Alkaline Phsphatase Activity Therefore, efforts were made to control the length of the 5 0 -extension by adjusting the amounts of enzyme. As mentioned above, it is highly likely that the action mode of T4 DNA polymerase-induced exogenous digestion, in the absence of dNTPs is processive. Once the enzyme attaches to the double-stranded substrate DNA fragment, it continues to remove the nucleotide monophosphate from 3 0 -end to the 5 0 -end of one strand. In order to digest one strand uniformly to a rather small extent, saturating amounts of enzyme molecules must react with the 3 0 -end of the DNA fragments within a relatively short incubation time. Alternatively, it is likely that the presence of a residual amount of dNTPs in the reaction mixture facilitates T4 DNA polymerase-induced non-processive digestion, since ethanol precipitation of the PCR products cannot completely remove the substrate dNTPs used in the PCR experiment. It is uncertain whether precise control was achieved, but representative experimental condition employed in the present study might partly satisfy this, since we always obtained mutationpositive clones with acceptable efficiency.
To construct plasmids possessing multiple mutations, we utilized the heterodimer system effectively. This approach allowed the following: once a set of almost identical plasmids with only a difference in the drugresistance genes was prepared, it was easy to exchange certain fragments, which is flanked by unique restriction sites, from one plasmid to another. 13) We believe that unless these two unique techniques are combined, T4 DNA polymerase-mediated rapid introduction of mutagenesis and the heterodimer system, it might be impossible to accomplish such studies.
To determine the function of the HBP35, a series of mutagenized plasmids were transformed into E. coli dsbA mutant JCB 572, and both alkaline phosphatase activity and motility on a soft agar plate were examined. Since this mutant exhibited the Km r trait, all mutation points introduced into the pResKmEcoHBP35 were transported to pResAmpEcoHBP35 by the heterodimer system (data not shown). It is natural to consider that the substitution of the one of two Cys residues at position 48 or 51 with Ser residue might have affected the complementation activity, since these two Cys residues consisted of the catalytic center for thioredoxin. That was the case in the complementation of alkaline phosphatase activity, since restoration by native hbp35 was lowered when the hbp35 with C48S and/or C51S mutations were transformed (Fig. 5) .
On the other hand, complementation of motile activity was rather complex (Fig. 6 ). It appeared that unlike the restoration of alkaline phosphatase activity, even the parental E. coli strain, JCB 572, possessed the residual disulfide bond forming activity specific for motility. To assess this activity, we initially used an agar concentration of 0.2%, as described by Udaka et al. 15) At that agar concentration, the parental strain harboring the ''blank'' plasmid, pResAmpEco showed only a little motile activity (data not shown). However, as it will be mentioned below, no motile activity was detected in E. coli transformants possessing the C48S mutation, or 1-Ser. In order to emphasize the difference between these two activities more clearly, LB plates containing 0.1% agar were used throughout this experiment. Note that this resulted an exaggeration of the residual motile activity found in the parental strain, N.
The colony size of the positive sample, P, was apparently larger than that of the negative sample. It is recognized that in the biological quantitation of antibiotics by paper disc, the size of the halo is logarithmically proportional to the total amounts of antibiotics. This means that the presence of limited amounts of antibiotic can readily be detected by the formation of a clear zone around the paper disc. Conversely, even in two large halos with only a slight difference in diameter, there exist vast differences in antibiotics between the two. It is not clear whether the motile activity of E. coli cells on a soft agar plate can be quantified in the same manner as that of antibiotics, since bacterial cells ''diffuse'' with multiplication in the former instance, but we believe native HBP35 has considerable compensatory effects on the motility of the dsb-defective mutant, JCB 572.
Since the motile activity in the transformants harboring the plasmid with C113S and/or C161S mutations was between that of the negative and positive controls, again, the effect of these two Cys residues, 113Cys and 161Cys, on this activity appeared to be low. However, this residual activity was completely abolished when the HBP35 with C48S substitution was introduced. Assuming that a putative protein responsible for motility can be active only when the disulfide bond is formed, i.e., oxidized form, the hbp35 with C48S mutation made this variant HBP35 an extremely strong reductant molecule. This abortive effect was observed even in the variant HBP35s with multiple substitutions, suggesting independence of the remaining three Cys residues. Since our preliminary experiment suggested that mutation of certain codons coding for His residues severely affected the redox state of the HBP35, His residues might participate in this phenomenon (data not shown).
In contrast, the transformant harboring the hbp35 with C51S mutation exhibited ''hyper-motility'' as compared to that harboring native hbp35. Invoking the abovementioned assumption, this mutation exerted the putative target protein a highly oxidized form. Recently, it was shown that the amino acid motif, Cys-x-x-Ser, can also function as the catalytic center for thiol/disulfide oxidoreductase. 20) In this context, we prepared the additional variant HBP35 with the C51A substitution, or Cys-x-x-Ala. Since the latter variant resulted in a background level of motile activity, the HBP35 with the C51S substitution can mimic thiol/disulfide oxidoreductase activity more effectively than native HBP35 only for the putative protein involved in the motility. These results suggest that the complementation scheme might be different between these two systems in E. coli JCB572.
Because the HBP35 appeares to be one of the key proteins responsible for adult periodontitis with versatile functions, it will be of interest to re-introduce mutagenized hbp35, constructed in the present study, back into the P. gingivalis chromosome to perform both transcriptome and proteome analyses.
